# Aethlon Medical Inc. (AEMD)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $634,475.94  
**Price:** $2.02 (+4.12%)

> Aethlon Medical Inc. is a medical technology company focused on developing immunotherapeutic products for cancer and infectious disease. Its primary platform, the Aethlon Hemopurifier, is designed to reduce cancer-promoting exosomes and circulating viruses through extracorporeal blood filtration. The company’s work centers on clinical-stage solutions that address life- and organ-threatening conditions, with applications that intersect oncology, virology, and critical care medicine. Aethlon Medical serves the broader healthcare market by advancing device-based technologies intended for diagnostic and therapeutic use in severe diseases. Headquartered in San Diego, California, Aethlon Medical Inc. operates as a specialized developer of highly targeted medical treatments within the biotechnology and medical device sectors.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2024 | — | — | -$13M | -$12M | — |
| 2023 | $574,245 | — | -$12M | -$12M | — |
| 2022 | $294,165 | — | -$10M | -$10M | — |
| 2021 | $659,104 | — | -$8M | -$8M | — |
| 2020 | $650,187 | — | -$6M | -$6M | — |
| 2019 | $229,625 | — | -$6M | -$6M | — |
| 2018 | $149,625 | — | -$5M | -$6M | — |
| 2017 | $392,073 | — | -$6M | -$7M | — |
| 2016 | $886,572 | — | -$4M | -$5M | — |
| 2015 | $762,417 | — | -$4M | -$7M | — |
| 2014 | $2M | — | -$3M | -$13M | — |
| 2013 | $1M | — | -$4M | -$5M | — |
| 2012 | $1M | — | -$3M | -$8M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2024 | $8M | $2M | $6M | $5M | — |
| 2023 | $18M | $2M | $15M | $15M | — |
| 2022 | $19M | $2M | $17M | $17M | — |
| 2021 | $11M | $1M | $9M | $10M | — |
| 2020 | $10M | $1M | $9M | $10M | — |
| 2019 | $4M | $2M | $2M | — | — |
| 2018 | $7M | $1M | $6M | — | — |
| 2017 | $2M | $1M | $676,379 | — | — |
| 2016 | $3M | $1M | $2M | — | — |
| 2015 | $1M | $729,205 | $615,450 | — | — |
| 2014 | $2M | $16M | -$15M | — | — |
| 2013 | $496,694 | $10M | -$9M | — | — |
| 2012 | $838,694 | — | -$9M | — | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2026 | -$7M | $3,704 | -$7M |
| 2025 | -$8M | — | -$8M |
| 2024 | -$10M | $250,867 | -$10M |
| 2023 | -$11M | $943,109 | -$11M |
| 2022 | -$10M | $349,193 | -$10M |
| 2021 | -$7M | $59,881 | -$7M |
| 2020 | -$5M | $151,665 | -$5M |
| 2019 | -$4M | — | -$4M |
| 2018 | -$4M | $24,823 | -$4M |
| 2017 | -$4M | $16,433 | -$4M |
| 2016 | -$4M | $9,307 | -$4M |
| 2015 | -$5M | — | -$5M |
| 2014 | -$2M | $96,056 | -$2M |
| 2013 | -$2M | — | -$2M |
| 2012 | -$2M | $1,735 | -$2M |

Source: [CompaniesByCap](https://companiesbycap.com/company/AEMD)